Investigators have developed and tested a new biomarker assay for quantifying disease and detecting the presence of neuroblastoma even when standard evaluations yield negative results for the disease. Researchers provide the first systematic comparison of standard imaging evaluations versus the new assay that screens for five different neuroblastoma-associated genes and determine that the new assay improves disease assessment and provides prediction of disease progression.
from Top Health News – ScienceDaily http://ift.tt/2u0omgv
from Tumblr http://ift.tt/2t6N2qX
No comments:
Post a Comment